Weighty cancer discovery
Researchers at Israel’s Weizmann Institute have analyzed the build-up of ammonia that impairs immune cells in 50% of cancer patients. It blocks the protein regulator HNF4-alpha, causing weight loss and tumor growth. In lab tests, restoring HNF4-alpha production stops weight loss and shrinks the tumors.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink